The roles of KDM5C and KDM5D in malignancies are less defined, although, in contrast to KDM5A and KDM5B, it is generally reduction of these proteins that is observed in cancers, most notably renal carcinomas (Tricarico et al., 2020). Here, KDM5A is linked to cancer.